Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-14

FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approved Baxter's original application for pantoprazole sodium in 0.9% sodium chloride. It is a proton pump inhibitor used to treat acid-related disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pantoprazole Sodium in 0.9% Sodium Chloride (pantoprazole sodium)

Snippet

ORIG AP for PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE)